HomeGTBP • NASDAQ
GT Biopharma Inc
add
$3.21
5.59%
After Hours:(0.93%)-0.030
$3.18
Closed: Jun 23, 7:10:57 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.93M | -37.50% |
Net income | -776.00K | 65.75% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.37M | -75.88% |
Total assets | 2.66M | -73.18% |
Total liabilities | 3.64M | -20.91% |
Total equity | -980.00K | — |
Shares outstanding | 2.59M | — |
Price to book | -7.79 | — |
Return on assets | -140.20% | — |
Return on capital | 364.53% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -776.00K | 65.75% |
Cash from operations | -2.20M | 47.11% |
Cash from investing | — | — |
Cash from financing | 616.00K | — |
Net change in cash | -1.59M | -282.09% |
Free cash flow | -3.48M | 9.10% |
Previous close
$3.04
Day range
$2.98 - $3.27
Year range
$1.72 - $4.10
Market cap
10.11M USD
Avg Volume
81.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1965
Headquarters
Website
Employees
1